Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

MK-677 vs Ipamorelin

Edited by Gabriel BrocklesbyFounder & EditorFact-checked

Both are referenced as growth hormone secretagogues in performance and longevity clinic listings. MK-677 is orally active while ipamorelin is typically injectable. Compare clinic listings by service scope and monitoring protocols.

MK-677 and ipamorelin are often referenced in performance or longevity contexts. Clinics vary in how they position each option within protocols. Use this page to compare provider models and monitoring standards.

Related comparison paths

Move from this comparison into the peptide pages and relevant clinic profiles.

MK-677

A growth hormone secretagogue referenced in performance and longevity clinic listings. Not a peptide in the traditional sense.

Potential benefits

  • Often listed in performance-focused protocols.
  • Common in longevity clinic menus.

Considerations

  • Regulatory status varies.
  • Requires clinician-led assessment.
Best for: Comparing performance clinics and their monitoring models.

Ipamorelin

A GH secretagogue typically administered by injection in clinic protocols.

Potential benefits

  • Often paired with other secretagogues.
  • Common in longevity listings.

Considerations

  • Human evidence is limited.
  • Monitoring standards vary by clinic.
Best for: Evaluating hormone optimisation clinics and protocol transparency.
CategoryMK-677Ipamorelin
Directory contextInformational clinic and treatment comparison context.Informational clinic and treatment comparison context.
Common goalsCompare how clinics frame suitability, monitoring, and expected use cases.Compare how clinics frame suitability, monitoring, and expected use cases.
Guidance noteInformational listing only; suitability requires clinician review.Informational listing only; suitability requires clinician review.

Next step

Compare clinics offering these treatments

Use city pages and peptide-specific pages to move from general research into actual provider shortlists. That usually gives a better buying picture than comparing drug names alone.

Related clinics

The Catalyst Clinic logo

The Catalyst Clinic

London, United Kingdom5.05.0 out of 5

Doctor-led peptide advisory consultations in central London. Every protocol is built around comprehensive bloodwork and personally led by Dr Ethan Hausman-Marquis, who reports a PhD from the Karolinska Institute, with compounds sourced from GMP-certified, EMA-regulated pharmacies.

  • Google 5.0 (48)
Doctor-led clinical governance

From £600

View Profile

Conclusion

Choose based on provider quality and monitoring rather than delivery format. Both are clinic-dependent and require clinician oversight.

Frequently asked questions

How do MK-677 and ipamorelin differ?

MK-677 is an orally active secretagogue with a longer duration, while ipamorelin is an injectable peptide secretagogue with a shorter, more selective action. Clinics weigh these differences alongside monitoring and goals.

Are they ever discussed together?

Some clinics reference them within broader growth hormone support discussions, but the format, dosing, and monitoring differ, so clinician guidance matters.

What matters most when comparing providers?

Clinical governance: licensed assessment, clear eligibility criteria, transparent monitoring, and realistic, non-promissory framing of outcomes.

Related peptide pages

US city pages

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.